teva

Tag details

Welcome to the 'teva' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'teva'.

Look up Offsite Link "teva" at The Free Dictionary

Latest blogosphere posts tagged “teva”

  • Cocaine Contaminant Levamisole Was Once Cancer Drug In Us


    Pharmainfo.netAuthority Authority: 172
    Cocaine Contaminant Levamisole Was Once Cancer Drug In Us Advertisement: read more
    1 day ago
  • (TEVA) Teva Pharmaceutical Industries Bolsters Position in Japan


    Stock Blog HubAuthority Authority: 465
    Generic player Teva Pharmaceutical Industries Ltd. (TEVA ) recently announced that its joint venture in Japan will acquire a majority stake in Taisho Pharmaceutical Industries, Ltd. Teva-KOWA Pharma Co., Ltd., Teva’s joint venture in Japan with KOWA Company, Ltd., will acquire at least 66.7% of Taisho’s ...
    1 day ago
  • Teva Bolsters Position in Japan


    Pharmainfo.netAuthority Authority: 172
    Teva Bolsters Position in Japan Zacks.com - 3 minutes ago Generic player Teva Pharmaceutical Industries Ltd. (TEVA - Snapshot Report) recently announced that its joint venture in Japan will acquire a majority stake in Taisho Pharmaceutical Industries ... Advertisement: read more
    1 day ago
  • Teva Bolsters Its Position in Japan


    SeekingAlpha.com: Home PageAuthority Authority: 649
    Zacks.com submits: Generic player Teva Pharmaceutical Industries Ltd. ( TEVA ) recently announced that its joint venture in Japan will acquire a majority stake in Taisho Pharmaceutical Industries, Ltd. Teva-KOWA Pharma Co., Ltd., Teva’s joint venture in Japan with KOWA Company, Ltd., will acquire at least 66.7% ...
    1 day ago
  • How Isis Benefits Teva-OncoGenex Deal


    SeekingAlpha.com: Home PageAuthority Authority: 649
    Zacks.com submits: Isis Pharmaceuticals, Inc. ( ISIS ) stands to benefit from the recently signed agreement between OncoGenex Pharmaceuticals ( OGXI ) and Teva Pharmaceutical Industries Ltd. ( TEVA ) for the development and commercialization of OGX-011. As Isis had co-discovered OGX-011 with OncoGenex, Isis is ...
    1 day ago
  • Revised Azilect Labeling Allows Use With OTC Cough, Cold Drugs


    Pharmainfo.netAuthority Authority: 172
    Revised Azilect Labeling Allows Use With OTC Cough, Cold Drugs FDA news - 1 hour ago The FDA has approved revised labeling for Teva Pharmaceutical Industries Parkinsons disease drug Azilect. The new prescribing information reflects less concern about the use of Azilect ... Advertisement: read more
    2 days ago
  • Good Deals on Teva Shoes at 6pm with 60% Off Each Style


    Uberi.comAuthority Authority: 167
    Good deals on Teva Shoes at 6pm with 60% off each style.  Here is a screenshot for your reference.  Shipping starts at $6.95.  Categories and some examples are listed.Womens Shoes Ventura Cork 2 Wedge for $30.00Mountain Scuff Suede for $28.00Mens ShoesHurricane 3 Sandal for $16.00Pelican Slip-on for $38.00
    2 days ago
  • (ISIS) Isis Pharmaceuticals Gains from Teva-OncoGenex Deal


    Stock Blog HubAuthority Authority: 465
    Isis Pharmaceuticals, Inc. ( ISIS ) stands to benefit from the recently signed agreement between OncoGenex Pharmaceuticals ( OGXI ) and Teva Pharmaceutical Industries Ltd. ( TEVA ) for the development and commercialization of OGX-011. As Isis had co-discovered OGX-011 with OncoGenex, Isis is entitled to receive ...
    2 days ago
  • Teva Invites Public to Listen to Analyst Meeting Webcast


    Pharmainfo.netAuthority Authority: 172
    Teva Invites Public to Listen to Analyst Meeting Webcast Business Wire - 26 minutes ago JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) invites investors and the general public to listen to a webcast of an analyst meeting on Thursday, January 7, 2010 ... Advertisement: read ...
    2 days ago
  • Five Fast-Growing Stocks to Own in 2010


    TheStreet.comAuthority Authority: 474
    Teva Pharmaceuticals, DeVry, OReilly Automotive, Neogen and Lincoln are rated buy.
    2 days ago
  • Watson Pharmaceuticals: Look-Ahead to December 2009 Quarterly Results


    SeekingAlpha.com: Home PageAuthority Authority: 649
    Neil Carvin submits: Watson Pharmaceuticals, Inc. (NYSE: WPI ) earned $63.0 million in the third quarter of 2009, down from $71.1 million in the same quarter of last year. Good operating results were masked by lower non-operating income and higher non-operating expenses. In November, we examined Watsons ...
    2 days ago
  • WPI: Look Ahead to December 2009 Quarterly Results


    Financial GaugesAuthority Authority: 421
    Watson Pharmaceuticals, Inc. ( NYSE: WPI ) earned $63.0 million in the third quarter of 2009, down from $71.1 million in the same quarter of last year.  Good operating results were masked by lower non-operating income and higher non-operating expenses.  In November, we examined Watsons Income Statement for ...
    2 days ago
  • Shumway Increases Long Exposure Through Blue Chips


    SeekingAlpha.com: Home PageAuthority Authority: 649
    Market Folly submits: This is the third quarter 2009 edition of our hedge fund portfolio tracking series. If youre unfamiliar with tracking hedge fund movements or SEC filings, check out our series preface on hedge fund 13F filings . Next up in our series is Chris Shumways hedge fund firm, Shumway Capital ...
    2 days ago
  • (CEPH) Cephalon Learns FDA Delays Nuvigil Decision


    Stock Blog HubAuthority Authority: 465
    The U.S. Food and Drug Administration (FDA) recently informed Cephalon, Inc. ( CEPH ) that it will require more time to review the supplemental new drug application (sNDA) submitted by the company for Nuvigil. Cephalon had filed the sNDA in June 2009, seeking to expand Nuvigil’s label as a treatment for improving ...
    2 days ago
  • (TEVA) Teva Pharmaceutical Expands Cancer Portfolio


    Stock Blog HubAuthority Authority: 465
    In a move to expand its branded product offering, generic player Teva Pharmaceutical Industries Ltd. ( TEVA ) recently entered into a global license and collaboration agreement with OncoGenex Pharmaceuticals, Inc. ( OGXI ). Teva and OncoGenex are collaborating for the development and commercialization of ...
    2 days ago
  • Teva Toachi Sandals for $29.99, or $38.94 Shipped


    Uberi.comAuthority Authority: 167
    Teva Toachi Sandals for Women for $29.99.  It is available for Men in Black or Midnight Navy colors.  Shipping is $8.95 or pick up in-store to save on shipping.  The total comes to $38.94 shipped.  Here is a screenshot for reference.  This sandal usually goes for over $55.
    3 days ago
  • Teva Expands Cancer Portfolio


    SeekingAlpha.com: Home PageAuthority Authority: 649
    Zacks.com submits: n a move to expand its branded product offering, generic player Teva Pharmaceutical Industries Ltd. ( TEVA ) recently entered into a global license and collaboration agreement with OncoGenex Pharmaceuticals, Inc. ( OGXI ). Teva and OncoGenex are collaborating for the development and ...
    3 days ago
  • Teva-Kowa Pharma to acquire majority stake in Taisho Pharmaceutical


    Pharmainfo.netAuthority Authority: 172
    Teva-Kowa Pharma to acquire majority stake in Taisho Pharmaceutical istockAnalyst.com - 1 hour ago (Source: Datamonitor) Teva Pharmaceutical Industries has reported that Teva-Kowa Pharma, the companys joint venture in Japan with Kowa Company, has signed a definitive agreement to acquire a ... Advertisement: ...
    3 days ago
  • Isis Pharma receives US$ 10 mn from OncoGenex license of OGX-O11 to Teva


    Pharmainfo.netAuthority Authority: 172
    Isis Pharma receives US$ 10 mn from OncoGenex license of OGX-O11 to Teva pharmabiz.com - 32 minutes ago Isis Pharmaceuticals, Inc will receive a US$ 10 million payment from OncoGenex Pharmaceuticals, Inc as a result of OncoGenex license of OGX-011 to Teva Pharmaceutical Industries Ltd. OGX-011 is a ... ...
    3 days ago
  • Teva-Kowa Pharma to acquire majority stake in Taisho Pharmaceutical


    Pharmainfo.netAuthority Authority: 172
    Teva-Kowa Pharma to acquire majority stake in Taisho Pharmaceutical istockAnalyst.com - 5 minutes ago (Source: Datamonitor)Teva Pharmaceutical Industries has reported that Teva-Kowa Pharma, the companys joint venture in Japan with Kowa Company, has signed a definitive agreement to acquire a ... Advertisement: ...
    3 days ago

Comments about teva

Personal attacks are NOT allowed
Please read our comment policy